Clinical Trial Update: Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer [NA]

View source ↗

Summary

A clinical trial is assessing gut microbiome changes during abemaciclib therapy in breast cancer, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)

Snippet

Sponsor: University of Vermont Medical Center | Conditions: Breast Cancer, HER-2 Positive Breast Cancer | NA | Status: NOT_YET_RECRUITING